CC-100
- Generic Name
- CC-100
CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Chemigen, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT03049046
- Locations
- 🇺🇸
Indiana University, IU Health Physicians Neurology, Indianapolis, Indiana, United States
CC100: Safety and Tolerability of Single Doses
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2015-04-30
- Lead Sponsor
- Chemigen, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT02050334
- Locations
- 🇺🇸
IU Health Neuroscience Center, Indianapolis, Indiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath